
zzso zzso Cell zzso zzso is the first of a new class of targeted, zzso drugs that show promise in the treatment of zzso These agents induce zzso zzso programmed cell zzso in a broad range of zzso and zzso zzso without affecting normal zzso The zzso effect of zzso appears to be the result of zzso of protein zzso G zzso which leads to multiple downstream effects culminating in zzso zzso has demonstrated zzso activity in solid zzso and zzso cancer cell lines and is an inhibitor of zzso growth in zzso models of zzso zzso zzso zzso and lung zzso zzso data evaluating selective zzso zzso drugs zzso in combination with various chemotherapy drugs indicates additive or synergistic zzso zzso In clinical studies, zzso prevented zzso zzso formation in patients with familial zzso zzso zzso over 24 zzso In a zzso zzso study of prostate cancer patients, zzso inhibited the rise of zzso zzso zzso in men with zzso progression after radical zzso zzso has been zzso by most patients in clinical zzso In conclusion, zzso evidence and early clinical results suggest that zzso and other drugs in this class may have wide applications in treating cancer both as zzso and in combination with chemotherapy and other targeted zzso 

